Publications by authors named "E Fuseau"

Claim this Profile
P
Population pharmacokinetics of a triple-secured fibrinogen concentrate administered to afibrinogenaemic patients: Observed age- and body weight-related differences and consequences for dose adjustment in children.
Anne Bellon, Eliane Fuseau, Olivier Roumanie, Jennifer Lamazure, Wil Stevens

Br J Clin Pharmacol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralization of EP217609, a new dual-action FIIa/FXa anticoagulant, by its specific antidote avidin: a phase I study.
P Gueret, S Combe, C Krezel, E Fuseau, P L M van Giersbergen

Eur J Clin Pharmacol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First in man study of EP217609, a new long-acting, neutralisable parenteral antithrombotic with a dual mechanism of action.
Pierre Gueret, S Combe, C Krezel, E Fuseau, P L M van Giersbergen

Eur J Clin Pharmacol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in collecting pharmacokinetic and pharmacodynamic information in an intensive care setting: PK/PD modelling of clazosentan in patients with aneurysmal subarachnoid haemorrhage.
Jochen Zisowsky, Eliane Fuseau, Shirin Bruderer, Andreas Krause, Jasper Dingemanse

Eur J Clin Pharmacol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EP42675, a synthetic parenteral dual-action anticoagulant: pharmacokinetics, pharmacodynamics, and absence of interactions with antiplatelet drugs.
P Gueret, C Krezel, E Fuseau, P L M van Giersbergen, M Petitou

J Thromb Haemost· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis